by AIP Online Bureau | Jan 20, 2022 | Health, Indian News, Pandemic, Policy, Regulation
“The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) which reviewed SII and Bharat Biotech’s application for the second time on Wednesday has recommended granting regular market approval to Covishield...
by AIP Online Bureau | Jan 12, 2022 | Facts, Health, Pandemic
“The neutralisation activity of Covaxin-boosted sera was comparable to what has been observed in mRNA vaccine-boosted sera against the Omicron variant.More than 90% of all individuals boosted with Covaxin showed neutralising antibodies,”Bharat Biotech said...
by AIP Online Bureau | Dec 28, 2021 | Health, Indian News, Pandemic, Policy
“This (Covaxin) is the only vaccine with emergency use listing for the age-group 15-18,” the federal health ministry said on Monday An expert committee of India’s drug regulator recommended emergency use authorisation for Merck’s COVID-19 pill...
by AIP Online Bureau | Nov 24, 2021 | Facts, Health, Pandemic
Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal. The results of an interim study recently...
by AIP Online Bureau | Nov 13, 2021 | Health, Indian News, Non-Life, Pandemic, Workplace/Employee Benefits
.. Ministry of External Affairs (MEA) Spokesperson Arindam Bagchi said 96 countries have either accepted WHO-approved vaccines, which would include both Covishield and Covaxin, or in some cases only Covishield or Covaxin .“But we hope that with the WHO approval to...
